SMAD2 and Myocardial fibrosis: Increased expression of FGF-21 has been shown to inactivate the TGF-β1-Smad2/3-MMP2/9 signaling pathway, thereby mitigating myocardial fibrosis, oxidative stress, and cell apoptosis (Ma et al., 2021).